Latest Breaking News On - Phasei program - Page 1 : comparemela.com

Dr Yap on the Continued Investigation of Saruparib in Advanced Solid Tumors

Dr Yap on the Continued Investigation of Saruparib in Advanced Solid Tumors
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

United statesTimothy yapDepartment of thoracic headTherapeutics discovery divisionKhalifa institute for personalized cancer therapyUniversity of texas md anderson cancer centerInvestigational cancer therapeuticsPhasei programNeck medical oncologyKhalifa institutePersonalized cancer therapyCancer center

Dr Yap on the Investigation of Saruparib in Solid Tumors

Timothy Yap, MBBS, PhD, FRCP, discusses the rationale for investigating saruparib in advanced solid tumors, such as prostate cancer with genetic mutations.

United statesTimothy yapDepartment of thoracic headKhalifa institute for personalized cancer therapyUniversity of texas md anderson cancer centerTherapeutics discovery divisionInvestigational cancer therapeuticsPhasei programNeck medical oncologyKhalifa institutePersonalized cancer therapyCancer center

First-in-Class PARP1 Selective Inhibitor Saruparib Shines in Phase 1 Trial of Advanced Solid Tumors

Timothy Yap, MBBS, PhD, FRCP, discusses encouraging data seen with the first-in-class PARP1 selective inhibitor saruparib in solid tumors and how the agent is being further investigated.

United statesTimothy yapTherapeutics discovery divisionTranslational researchUniversity of texas md anderson cancer centerKhalifa institute for personalized cancer therapyClinical developmentInvestigational cancer therapeuticsPhasei programNeck medical oncologyCancer centerKhalifa institutePersonalized cancerProject optimus

Novel CDK4 Inhibitor Shows Activity and Safety in HR+/HER2– Metastatic Breast Cancer

Novel CDK4 Inhibitor Shows Activity and Safety in HR+/HER2– Metastatic Breast Cancer
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomRadiopharm theranosticsInstitut gustave roussyTimothya yapEli lillyClinical developmentCancer research united kingdomUniversity of texas md anderson cancer centerTranslational researchBaptist health systemsBreast cancer congressBristol myers squibbKhalifa institute for personalized cancer therapyInstitute for applied cancer scienceTherapeutics discovery division

Dr Yap on Saruparib in BRCA1/2+, PALB2+, or RAD51C/D+ Advanced Solid Tumors

Dr Yap on Saruparib in BRCA1/2+, PALB2+, or RAD51C/D+ Advanced Solid Tumors
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

United statesTimothy yapTherapeutics discovery divisionDepartment of thoracic headUniversity of texas md anderson cancer centerKhalifa institute for personalized cancer therapyInvestigational cancer therapeuticsPhasei programNeck medical oncologyKhalifa institutePersonalized cancer therapyCancer center